Unlock the power of cannabis in cosmetics with expert testing and compliance.
Ensure the safety and efficacy of your cosmetic medical devices with our comprehensive testing services.
Perfumes must undergo rigorous testing to ensure safety, efficacy, consumer perception, stability, and regulatory compliance.
Rising demand for innovative, safe ingredients makes regulatory compliance crucial.
Ensuring safety and efficacy of sunscreen products with rigorous SPF, UVA, and claim‑support testing for global compliance.
Ensuring the safety, quality, and performance of hair care products with advanced testing services.
Ensure the safety and efficacy of your nutraceuticals with our expert regulatory support and comprehensive testing services.
Ensure the safety and efficacy of your pet care products with our comprehensive testing services.
Testing cosmetics and personal care products for sensitive skin to ensure safety and effectiveness.
Ensure the safety & compliance of tattoo and permanent make-up products.
Ensuring the safety, efficacy, and quality of makeup products with advanced testing solutions.
Cosmetic packaging is vital for product safety, stability, and efficacy.
Our pharmaceutical dermatology team guides strategic, regulatory & clinical development of dermatology products from early stage to market.
Ensuring the safety, efficacy, and marketability of skincare products with advanced testing services.
Ensure compliance and safety with our comprehensive regulatory and toxicology solutions.
Ensure your cosmetic products’ environmental safety with our ecotoxicity and biodegradability testing.
Experience precise and reliable efficacy tests using ex vivo human skin explants to evaluate the effects of your cosmetic products.
Gain actionable insights into consumer preferences and sensory experiences.
Ensure global compliance and optimise operational efficiency with tailored auditing, consulting, and training solutions.
Our expert analytical testing verifies raw materials, products and packaging for safety, quality and compliance.
Discover personalised skincare solutions with advanced genomic analysis to enhance your skin's health and beauty.
Conduct robust in vivo clinical trials to ensure product safety, efficacy, and consumer satisfaction.
Measure the emotional impact of your products with cutting-edge techniques.
Enhance operational efficiency, ensure compliance, and achieve exceptional results with our dedicated on-site teams.
Microbiological quality is critical in cosmetics product safety. Contamination affects safety, stability and reputation.
Explore our comprehensive in vitro testing services to ensure the safety and efficacy of your cosmetic products.
Substantiate efficacy claims with cutting-edge digital imaging technologies and our in-house software.
Support your green claims with trusted testing, from biodegradability to recycled packaging.
Discover our monthly bulletins and exclusive insights from our international network of laboratories
Subscribe to our newsletter and receive the latest news, expert insights, and upcoming events from Eurofins C&PC.
Contact us for expert advice and tailor-made solutions to ensure the quality and safety of your products.
Eurofins C&PC is a global leader in cosmetic & personal care product testing. Discover our global locations!
The long awaited, and widely anticipated, implementing decree No.2025-1376 of 28 December 2025 for the French PFAS ban has now been published in the Official Journal of 30 December 2025. After months of intense interministerial discussions, the Prime Minister’s office finalised the text, confirming the conditions under which the national prohibition on PFAS will apply to cosmetic products.
Compared with the earlier draft reviewed and commented on by industry stakeholders, the final decree maintains the three threshold values defining non-compliance, aligned with current discussions at the European level:
The decree confirms the legal application date of 1 January 2026, as set by Law No. 2025 188.
However, it introduces a 12 month sell through period for products manufactured before 1 January 2026. These products may remain on the market until 31 December 2026.
For the record, the ban applies to finished cosmetic products, covering:
This second aspect represents the greatest compliance challenge for the cosmetics sector. PFAS contamination may arise from raw materials, processing aids, manufacturing environments, or packaging interactions - making analytical verification and supply chain control essential.
Importantly, the French threshold values and compliance principles set out in the implementing decree are identical to those currently envisaged under the forthcoming European PFAS restriction. France is therefore acting as a regulatory forerunner, anticipating at national level the framework that is expected to apply across the European Union in the coming years.
In August 2025, the European Chemicals Agency (ECHA) published an updated version of the PFAS restriction proposal. This revised text was prepared by the five Member States behind the initial restriction intention (Germany, the Netherlands, Denmark, Sweden and Norway), following an in-depth assessment of the comments received during the public consultation.
The updated proposal includes an expanded and revised list of derogations. However, no derogation is foreseen for cosmetic products, as the substitution of PFAS in cosmetics had already been assessed as both technically and economically feasible. Proposed derogations mainly concern:
As of 25 September 2025, it was confirmed that the preliminary opinions of ECHA’s Committee for Risk Assessment (RAC) and Committee for Socio Economic Analysis (SEAC) are expected to be available in March 2026. These draft opinions will then be opened to public consultation for a period of two months.
The final RAC and SEAC opinions are expected by the end of 2026, in line with earlier announcements.
Following the adoption of the final opinions, the restriction proposal will be discussed at European Commission level. If endorsed, it will be translated into a regulation amending Annex XVII of REACH.
Based on the current indicative timeline, publication of the REACH amendment could be envisaged in 2027, marking the formal entry into force of a harmonised European PFAS restriction, including cosmetics, closely mirroring the regime already implemented in France.
Companies that ensure compliance with the French PFAS thresholds, analytical requirements and supply chain controls today will be well positioned to meet future European obligations tomorrow. In this context, proactive raw material screening, robust supplier engagement, and validated analytical strategies are no longer optional, they are becoming foundational elements of regulatory compliance in the European cosmetics market.